tiprankstipranks
Advertisement
Advertisement
Jenscare Wins New Zealand Approval for Key Transcatheter Heart Valves
PremiumCompany AnnouncementsJenscare Wins New Zealand Approval for Key Transcatheter Heart Valves
2M ago
Jenscare Wins FDA Green Light for Pivotal U.S. Trial of LuX-Valve Plus
Premium
Company Announcements
Jenscare Wins FDA Green Light for Pivotal U.S. Trial of LuX-Valve Plus
3M ago
Jenscare Projects Up to RMB110 Million in First-Year Commercial Revenue on Strong Ken-Valve Uptake
Premium
Company Announcements
Jenscare Projects Up to RMB110 Million in First-Year Commercial Revenue on Strong Ken-Valve Uptake
3M ago
Jenscare Scientific Announces 2025 Extraordinary General Meeting
PremiumCompany AnnouncementsJenscare Scientific Announces 2025 Extraordinary General Meeting
5M ago
Jenscare Scientific Announces Book Closure for 2025 EGM
Premium
Company Announcements
Jenscare Scientific Announces Book Closure for 2025 EGM
5M ago
Jenscare Scientific’s LuX-Valve Plus Shows Promising Results in Large Annulus Patients
Premium
Company Announcements
Jenscare Scientific’s LuX-Valve Plus Shows Promising Results in Large Annulus Patients
6M ago
Jenscare’s LuX-Valve Plus Gains Approval for Greater Bay Area Clinical Use
PremiumCompany AnnouncementsJenscare’s LuX-Valve Plus Gains Approval for Greater Bay Area Clinical Use
7M ago
Jenscare Scientific Cancels Book Closure Period for EGM
Premium
Company Announcements
Jenscare Scientific Cancels Book Closure Period for EGM
7M ago
Jenscare Scientific Co., Ltd. Announces 2025 Extraordinary General Meeting to Consider Issuance Mandate
Premium
Company Announcements
Jenscare Scientific Co., Ltd. Announces 2025 Extraordinary General Meeting to Consider Issuance Mandate
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100